Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SAKAR.NS Stock Summary
Top 10 Correlated ETFs
SAKAR.NS
In the News
SAKAR.NS Financial details
Company Rating
Buy
Market Cap
8.04B
Income
144.11M
Revenue
1.47B
Book val./share
109.49
Cash/share
0.15
Dividend
-
Dividend %
-
Employees
297
Optionable
No
Shortable
Yes
Earnings
08 Feb 2024
P/E
56.61
Forward P/E
-
PEG
-19.36
P/S
5.47
P/B
3.44
P/C
2539
P/FCF
-
Quick Ratio
0.44
Current Ratio
1.23
Debt / Equity
0.29
LT Debt / Equity
0.27
-
-
EPS (TTM)
7.14
EPS next Y
-
EPS next Q
-
EPS this Y
-32.01%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.86%
Revenue last 5Y
14.34%
Revenue Q/Q
-12.59%
EPS Q/Q
15.07%
-
-
-
-
SMA20
4.99%
SMA50
19.14%
SMA100
53.97%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
14%
ROC
0.07%
Gross Margin
47%
Oper. Margin
16%
Profit Margin
10%
Payout
-
Shs Outstand
21.35M
Shs Float
8.29M
-
-
-
-
Target Price
-
52W Range
185.55-419.5
52W High
-9.11%
52W Low
+105.86%
RSI
51.61
Rel Volume
0.05
Avg Volume
40.41K
Volume
1.89K
Perf Week
-2.71%
Perf Month
13.2%
Perf Quarter
47.87%
Perf Half Y
48.28%
-
-
-
-
Beta
0.586
-
-
Volatility
3.82%, 19.69%
Prev Close
1.18%
Price
380.85
Change
2.1%
SAKAR.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 50.24 | 55.46 | 6.28K | 84.92 | 71.73 | |
Net income per share | 5.16 | 6.43 | 708.58 | 10.05 | 6.86 | |
Operating cash flow per share | 14.06 | 6.77 | 966.88 | 23.64 | 18.99 | |
Free cash flow per share | -4.27 | -2.37 | -1.39K | -40.95 | -25.21 | |
Cash per share | 0.27 | 0.2 | 5.47 | 4.73 | 1.89 | |
Book value per share | 52.78 | 54.35 | 6.53K | 84.41 | 93.23 | |
Tangible book value per share | 48.82 | 52.16 | 6.48K | 84.41 | 93.23 | |
Share holders equity per share | 52.78 | 54.35 | 6.53K | 84.41 | 93.23 | |
Interest debt per share | 9.86 | 12.57 | 2.98K | 61.72 | 63.03 | |
Market cap | 733.64M | 851.28M | 8.58M | 859.19M | 3.73B | |
Enterprise value | 847.51M | 1.02B | 433.73M | 1.79B | 4.84B | |
P/E ratio | 10.46 | 8.85 | 0.08 | 5.66 | 29.23 | |
Price to sales ratio | 1.07 | 1.03 | 0.01 | 0.67 | 2.8 | |
POCF ratio | 3.84 | 8.41 | 0.06 | 2.41 | 10.56 | |
PFCF ratio | -12.64 | -24.04 | -0.04 | -1.39 | -7.96 | |
P/B Ratio | 1.02 | 1.05 | 0.01 | 0.67 | 2.15 | |
PTB ratio | 1.02 | 1.05 | 0.01 | 0.67 | 2.15 | |
EV to sales | 1.24 | 1.22 | 0.46 | 1.39 | 3.63 | |
Enterprise value over EBITDA | 4.86 | 4.74 | 1.84 | 6.19 | 12.81 | |
EV to operating cash flow | 4.44 | 10.03 | 2.98 | 5.01 | 13.71 | |
EV to free cash flow | -14.6 | -28.67 | -2.07 | -2.89 | -10.33 | |
Earnings yield | 0.1 | 0.11 | 12.45 | 0.18 | 0.03 | |
Free cash flow yield | -0.08 | -0.04 | -24.44 | -0.72 | -0.13 | |
Debt to equity | 0.16 | 0.21 | 0.43 | 0.73 | 0.64 | |
Debt to assets | 0.12 | 0.15 | 0.24 | 0.35 | 0.33 | |
Net debt to EBITDA | 0.65 | 0.77 | 1.8 | 3.22 | 2.94 | |
Current ratio | 1.86 | 1.52 | 1.01 | 1.07 | 1.03 | |
Interest coverage | 6.69 | 6.44 | 6.48 | 61.64 | 3.21 | |
Income quality | 1.97 | 0.83 | 1.1 | 1.89 | 2.09 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0.01 | |
Intangibles to total assets | 0.05 | 0.03 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.3 | -1.35 | -2.44 | -2.73 | -2.33 | |
Capex to revenue | -0.36 | -0.16 | -0.38 | -0.76 | -0.62 | |
Capex to depreciation | -4.12 | -1.93 | -4.41 | -10.09 | -5.48 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 78.28 | 88.69 | 10.2K | 138.18 | 119.98 | |
ROIC | 0.09 | 0.11 | 0.09 | 0.08 | 0.05 | |
Return on tangible assets | 0.08 | 0.09 | 0.06 | 0.06 | 0.04 | |
Graham Net | -6.75 | -14.48 | -4.74K | -69.23 | -81.63 | |
Working capital | 120.45M | 74.14M | 4.54M | 32.62M | 14.24M | |
Tangible asset value | 663.25M | 780.4M | 977.22M | 1.27B | 1.73B | |
Net current asset value | -8.99M | -121.51M | -456.17M | -902.76M | -1.07B | |
Invested capital | 0.16 | 0.21 | 0.43 | 0.73 | 0.64 | |
Average receivables | 208.02M | 136M | 42.55M | 143.53M | 143.53M | |
Average payables | 41.98M | 47.15M | 126.1M | 251.42M | 282.96M | |
Average inventory | 53.94M | 88.95M | 133.15M | 149.4M | 147.9M | |
Days sales outstanding | 99.95 | 37.43 | 0 | 81.71 | 0 | |
Days payables outstanding | 40.8 | 45.34 | 140.21 | 148.82 | 129.47 | |
Days of inventory on hand | 70.11 | 91.11 | 111.27 | 69.2 | 76.42 | |
Receivables turnover | 3.65 | 9.75 | 0 | 4.47 | 0 | |
Payables turnover | 8.95 | 8.05 | 2.6 | 2.45 | 2.82 | |
Inventory turnover | 5.21 | 4.01 | 3.28 | 5.27 | 4.78 | |
ROE | 0.1 | 0.12 | 0.11 | 0.12 | 0.07 | |
Capex per share | -18.33 | -9.13 | -2.36K | -64.59 | -44.21 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.95 | 18.01 | 18.79 | 20.04 | 15.75 | |
Net income per share | 1.01 | 2.16 | 1.81 | 1.46 | 1.68 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 9.96 | 0 | 1.63 | 0 | 0.15 | |
Book value per share | 80.53 | 0 | 80.12 | 0 | 109.49 | |
Tangible book value per share | 80.53 | 0 | 80.12 | 0 | 109.49 | |
Share holders equity per share | 80.53 | 0 | 80.12 | 0 | 109.49 | |
Interest debt per share | 52.89 | 1.05 | 52.41 | 1.07 | 32.29 | |
Market cap | 1.1B | 4.17B | 4.34B | 4.99B | 7.37B | |
Enterprise value | 2.1B | 4.17B | 5.45B | 4.99B | 8.05B | |
P/E ratio | 14.08 | 25.95 | 27.66 | 43.93 | 50.65 | |
Price to sales ratio | 3.57 | 12.45 | 10.68 | 12.8 | 21.62 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.71 | 0 | 2.5 | 0 | 3.11 | |
PTB ratio | 0.71 | 0 | 2.5 | 0 | 3.11 | |
EV to sales | 6.85 | 12.45 | 13.41 | 12.8 | 23.61 | |
Enterprise value over EBITDA | 22.88 | 39.1 | 56.84 | 47.32 | 80.34 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.65 | 0 | 0.64 | 0 | 0.29 | |
Debt to assets | 0.34 | 0 | 0.33 | 0 | 0.19 | |
Net debt to EBITDA | 10.96 | 0 | 11.59 | 0 | 6.8 | |
Current ratio | 1.21 | 0 | 1.03 | 0 | 1.23 | |
Interest coverage | 5.47 | 3.37 | 2.8 | 2.17 | 3.52 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 42.78 | 0 | 57.17 | 0 | 64.33 | |
ROIC | 0.01 | 0 | 0.02 | 0 | 0.02 | |
Return on tangible assets | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Graham Net | -57.6 | 0 | -70.15 | 0 | -43.35 | |
Working capital | 97.49M | 191.77M | 14.24M | 35.23M | 106.46M | |
Tangible asset value | 1.55B | 0 | 1.73B | 0 | 2.37B | |
Net current asset value | -871.52M | 191.77M | -1.07B | 35.23M | -629.82M | |
Invested capital | 0.65 | 0 | 0.64 | 0 | 0.29 | |
Average receivables | 43M | 43M | 0 | 0 | 100.74M | |
Average payables | 64.37M | 64.37M | 130.44M | 130.44M | 89.38M | |
Average inventory | 59.81M | 59.81M | 76.99M | 76.99M | 111.67M | |
Days sales outstanding | 25.2 | 0 | 0 | 0 | 53.21 | |
Days payables outstanding | 67.89 | 0 | 104.48 | 0 | 95.4 | |
Days of inventory on hand | 63.07 | 0 | 61.66 | 0 | 119.19 | |
Receivables turnover | 3.57 | 0 | 0 | 0 | 1.69 | |
Payables turnover | 1.33 | 0 | 0.86 | 0 | 0.94 | |
Inventory turnover | 1.43 | 0 | 1.46 | 0 | 0.76 | |
ROE | 0.01 | 0 | 0.02 | 0 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SAKAR.NS Frequently Asked Questions
What is Sakar Healthcare Limited stock symbol ?
Sakar Healthcare Limited is a IN stock and trading under the symbol SAKAR.NS
What is Sakar Healthcare Limited stock quote today ?
Sakar Healthcare Limited stock price is $380.85 today.
Is Sakar Healthcare Limited stock public?
Yes, Sakar Healthcare Limited is a publicly traded company.